• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Advanced Magnetic Resonance Imaging for Early Diagnosis and Monitoring of Movement Disorders.用于运动障碍早期诊断和监测的先进磁共振成像
Brain Sci. 2025 Jan 16;15(1):79. doi: 10.3390/brainsci15010079.
2
Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.帕金森病和非典型帕金森综合征的神经影像学进展
Front Neurol. 2020 Oct 15;11:572976. doi: 10.3389/fneur.2020.572976. eCollection 2020.
3
Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.帕金森病及帕金森综合征中的影像学生物标志物:当前概念与新进展
Transl Neurodegener. 2017 Mar 28;6:8. doi: 10.1186/s40035-017-0076-6. eCollection 2017.
4
Free-water imaging in Parkinson's disease and atypical parkinsonism.帕金森病和非典型帕金森综合征中的自由水成像
Brain. 2016 Feb;139(Pt 2):495-508. doi: 10.1093/brain/awv361. Epub 2015 Dec 24.
5
Magnetic resonance imaging of the substantia nigra in Parkinson's disease.帕金森病黑质的磁共振成像。
Mov Disord. 2012 Jun;27(7):822-30. doi: 10.1002/mds.25015. Epub 2012 May 30.
6
Regional Selectivity of Neuromelanin Changes in the Substantia Nigra in Atypical Parkinsonism.非典型帕金森病患者黑质神经元黑色素改变的区域性选择性。
Mov Disord. 2022 Jun;37(6):1245-1255. doi: 10.1002/mds.28988. Epub 2022 Mar 29.
7
Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study.帕金森病自动影像鉴别(AID-P)的开发和验证:一项多中心机器学习研究。
Lancet Digit Health. 2019 Sep;1(5):e222-e231. doi: 10.1016/S2589-7500(19)30105-0. Epub 2019 Aug 27.
8
In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.中枢神经系统突触功能的体内成像:I. 运动障碍与痴呆
Behav Brain Res. 2009 Dec 1;204(1):1-31. doi: 10.1016/j.bbr.2009.06.008. Epub 2009 Jun 10.
9
Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.帕金森病诊断观察(PADDO):一项用于帕金森综合征早期鉴别诊断的前瞻性队列研究的研究原理与设计
BMC Neurol. 2018 May 16;18(1):69. doi: 10.1186/s12883-018-1072-x.
10
Precision Imaging in Neurodegeneration: The Superiority of Diffusion Tensor Imaging Over Conventional MRI in Differentiating Parkinson's Disease From Atypical Parkinsonian Syndromes.神经退行性疾病中的精准成像:在区分帕金森病与非典型帕金森综合征方面,扩散张量成像相较于传统磁共振成像的优势
Cureus. 2024 Sep 8;16(9):e68933. doi: 10.7759/cureus.68933. eCollection 2024 Sep.

引用本文的文献

1
Blueprint of Collapse: Precision Biomarkers, Molecular Cascades, and the Engineered Decline of Fast-Progressing ALS.崩溃蓝图:精准生物标志物、分子级联反应与快速进展性肌萎缩侧索硬化的人为衰退
Int J Mol Sci. 2025 Aug 21;26(16):8072. doi: 10.3390/ijms26168072.
2
Neural Correlates of Huntington's Disease Based on Electroencephalography (EEG): A Mechanistic Review and Discussion of Excitation and Inhibition (E/I) Imbalance.基于脑电图(EEG)的亨廷顿舞蹈病神经关联:兴奋与抑制(E/I)失衡的机制性综述与讨论
J Clin Med. 2025 Jul 15;14(14):5010. doi: 10.3390/jcm14145010.
3
MR-Guidance of Gene Therapy for Brain Diseases: Moving From Palliative Treatment to Cures.磁共振引导的脑部疾病基因治疗:从姑息治疗走向治愈
J Magn Reson Imaging. 2025 Apr 21. doi: 10.1002/jmri.29804.

本文引用的文献

1
Towards Transforming Neurorehabilitation: The Impact of Artificial Intelligence on Diagnosis and Treatment of Neurological Disorders.迈向变革性神经康复:人工智能对神经系统疾病诊断和治疗的影响。
Biomedicines. 2024 Oct 21;12(10):2415. doi: 10.3390/biomedicines12102415.
2
Frequency and Longitudinal Course of Behavioral and Neuropsychiatric Symptoms in Participants With Genetic Frontotemporal Dementia.遗传性额颞叶痴呆患者行为和神经精神症状的频率及纵向病程
Neurology. 2024 Oct 22;103(8):e209569. doi: 10.1212/WNL.0000000000209569. Epub 2024 Sep 16.
3
Utility of neuromelanin-sensitive MRI in the diagnosis of dementia with Lewy bodies.神经黑色素敏感 MRI 在路易体痴呆诊断中的应用。
PLoS One. 2024 Sep 9;19(9):e0309885. doi: 10.1371/journal.pone.0309885. eCollection 2024.
4
Multimodal neuroimaging to characterize symptom-specific networks in movement disorders.多模态神经影像学用于表征运动障碍中特定症状的网络。
NPJ Parkinsons Dis. 2024 Aug 14;10(1):154. doi: 10.1038/s41531-024-00774-3.
5
Neurochemical changes in the progression of Huntington's disease: A meta-analysis of in vivoH-MRS studies.亨廷顿病进展过程中的神经化学变化:体内 H-MRS 研究的荟萃分析。
Neurobiol Dis. 2024 Sep;199:106574. doi: 10.1016/j.nbd.2024.106574. Epub 2024 Jun 22.
6
Neuroimaging to Facilitate Clinical Trials in Huntington's Disease: Current Opinion from the EHDN Imaging Working Group.神经影像学在亨廷顿病临床试验中的应用:EHDN 影像学工作组的最新观点。
J Huntingtons Dis. 2024;13(2):163-199. doi: 10.3233/JHD-240016.
7
Hypothalamic involvement in multiple system atrophy: A structural MRI study.下丘脑在多系统萎缩中的作用:一项结构 MRI 研究。
J Neurol Sci. 2024 May 15;460:122985. doi: 10.1016/j.jns.2024.122985. Epub 2024 Apr 2.
8
Machine Learning Approaches to Identify Affected Brain Regions in Movement Disorders Using MRI Data: A Systematic Review and Diagnostic Meta-analysis.机器学习方法在使用 MRI 数据识别运动障碍中受影响的脑区:系统评价和诊断荟萃分析。
J Magn Reson Imaging. 2024 Dec;60(6):2518-2546. doi: 10.1002/jmri.29364. Epub 2024 Mar 27.
9
A rapid multi-parametric quantitative MR imaging method to assess Parkinson's disease: a feasibility study.一种快速多参数定量磁共振成像方法评估帕金森病:一项可行性研究。
BMC Med Imaging. 2024 Mar 5;24(1):58. doi: 10.1186/s12880-024-01229-0.
10
Neuromelanin-sensitive magnetic resonance imaging: Possibilities and promises as an imaging biomarker for Parkinson's disease.神经黑色素敏感磁共振成像:作为帕金森病成像生物标志物的可能性和前景。
Eur J Neurosci. 2024 May;59(10):2616-2627. doi: 10.1111/ejn.16296. Epub 2024 Mar 5.

用于运动障碍早期诊断和监测的先进磁共振成像

Advanced Magnetic Resonance Imaging for Early Diagnosis and Monitoring of Movement Disorders.

作者信息

Ortega-Robles Emmanuel, de Celis Alonso Benito, Cantillo-Negrete Jessica, Carino-Escobar Ruben I, Arias-Carrión Oscar

机构信息

Unidad de Trastornos del Movimiento y Sueño, Hospital General Dr. Manuel Gea González, Calzada de Tlalpan 4800, Mexico City 14080, Mexico.

Facultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico.

出版信息

Brain Sci. 2025 Jan 16;15(1):79. doi: 10.3390/brainsci15010079.

DOI:10.3390/brainsci15010079
PMID:39851446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11763950/
Abstract

Advanced magnetic resonance imaging (MRI) techniques are transforming the study of movement disorders by providing valuable insights into disease mechanisms. This narrative review presents a comprehensive overview of their applications in this field, offering an updated perspective on their potential for early diagnosis, disease monitoring, and therapeutic evaluation. Emerging MRI modalities such as neuromelanin-sensitive imaging, diffusion-weighted imaging, magnetization transfer imaging, and relaxometry provide sensitive biomarkers that can detect early microstructural degeneration, iron deposition, and connectivity disruptions in key regions like the substantia nigra. These techniques enable earlier and more accurate differentiation of movement disorders, including Parkinson's disease, progressive supranuclear palsy, multiple system atrophy, corticobasal degeneration, Lewy body and frontotemporal dementia, Huntington's disease, and dystonia. Furthermore, MRI provides objective metrics for tracking disease progression and assessing therapeutic efficacy, making it an indispensable tool in clinical trials. Despite these advances, the absence of standardized protocols limits their integration into routine clinical practice. Addressing this gap and incorporating these techniques more systematically could bring the field closer to leveraging advanced MRI for personalized treatment strategies, ultimately improving outcomes for individuals with movement disorders.

摘要

先进的磁共振成像(MRI)技术正在改变运动障碍的研究,为疾病机制提供有价值的见解。这篇叙述性综述全面概述了它们在该领域的应用,提供了关于其在早期诊断、疾病监测和治疗评估方面潜力的最新观点。新兴的MRI模式,如神经黑色素敏感成像、扩散加权成像、磁化传递成像和弛豫测量,提供了敏感的生物标志物,可以检测黑质等关键区域的早期微观结构退化、铁沉积和连接中断。这些技术能够更早、更准确地区分运动障碍,包括帕金森病、进行性核上性麻痹、多系统萎缩、皮质基底节变性、路易体和额颞叶痴呆、亨廷顿病和肌张力障碍。此外,MRI为跟踪疾病进展和评估治疗效果提供了客观指标,使其成为临床试验中不可或缺的工具。尽管有这些进展,但缺乏标准化方案限制了它们融入常规临床实践。解决这一差距并更系统地纳入这些技术,可以使该领域更接近利用先进的MRI制定个性化治疗策略,最终改善运动障碍患者的治疗效果。